Related references
Note: Only part of the references are listed.Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors
Suthee Rapisuwon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report
Hikaru Kamo et al.
BMC NEUROLOGY (2019)
Vogt-Koyanagi-Harada Syndrome Induced by Pembrolizumab in a Patient with Non-Small Cell Lung Cancer
Tomoki Tamura et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone et al.
LANCET ONCOLOGY (2018)
Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
Yuki Nakatani et al.
CASE REPORTS IN NEUROLOGY (2018)
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
Omar Abdel-Rahman et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone
Matthew T. Witmer
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
Dai Maruyama et al.
CANCER SCIENCE (2017)
Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma
Marion Bricout et al.
JOURNAL OF IMMUNOTHERAPY (2017)
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma
Leila Khoja et al.
ONCOLOGY LETTERS (2016)
Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report
Alfred Basilious et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2016)
A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab
Khawla Abu Samra et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2016)
Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma - Case Series and Review
F. C. Fierz et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2016)
Ipilimumab in anti-PD1 refractory metastatic melanoma: a report of eight cases
Aurelie Jacobsoone-Ulrich et al.
MELANOMA RESEARCH (2016)
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient
Elisabetta Miserocchi et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2015)
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2015)
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
Troy Z. Horvat et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Vogt-Koyanagi-Harada-like Syndrome After CTLA-4 Inhibition With Ipilimumab for Metastatic Melanoma
Jason N. Crosson et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma
Dimosthenis Mantopoulos et al.
JAMA OPHTHALMOLOGY (2015)
Influence of molecular genetics in Vogt-KoyanagiHarada disease
Joanne Y. W. Ng et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2014)
Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma
Bobeck S. Modjtahedi et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2013)
Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
Ahmad Tarhini
SCIENTIFICA (2013)
Ocular Toxicity of Targeted Therapies
Daniel J. Renouf et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Neurosensory retinal detachment due to sunitinib treatment
A. Wegner et al.
EYE (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Persistent Corneal Epithelial Defect Associated With Erlotinib Treatment
Keegan S. Johnson et al.
CORNEA (2009)
Ocular Side Effects Associated with Imatinib Mesylate and Perifosine for Gastrointestinal Stromal Tumor
S. Serdar Dogan et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic Melanoma
Steven Yeh et al.
OPHTHALMOLOGY (2009)
Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine
Debraj Shome et al.
OPHTHALMOLOGY (2008)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma - A new cause of uveitis
MR Robinson et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Share Paper
